Editorial
doi: 10.1111/j.1467-8519.2010.01855.x.
Why the Avandia scandal proves big pharma needs stronger ethical standards
- PMID: 21050246
- DOI: 10.1111/j.1467-8519.2010.01855.x
Item in Clipboard
Editorial
Why the Avandia scandal proves big pharma needs stronger ethical standards
Bioethics.
2010 Oct.
No abstract available
Similar articles
-
GSK is accused of trying to suppress editorial on rosiglitazone.BMJ. 2010 May 19;340:c2654. doi: 10.1136/bmj.c2654. BMJ. 2010. PMID: 20484354 No abstract available.
-
FDA puts restrictions on use of controversial diabetes drug.Mayo Clin Womens Healthsource. 2011 Feb;15(2):3. Mayo Clin Womens Healthsource. 2011. PMID: 21200371 No abstract available.
-
Drug safety. Planned study of Avandia in doubt after FDA review.Science. 2010 Jul 23;329(5990):375. doi: 10.1126/science.329.5990.375. Science. 2010. PMID: 20651123 No abstract available.
-
The truth about rosiglitazone (avandia).Nurse Pract. 2008 Jun;33(6):10-1. Nurse Pract. 2008. PMID: 18528195 Review. No abstract available.
-
Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.Diabetes Care. 2007 Dec;30(12):3141-4. doi: 10.2337/dc07-1908. Diabetes Care. 2007. PMID: 18042753 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
